• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

125I标记的C反应蛋白和125I标记的修饰C反应蛋白在CD-1小鼠体内的生物分布与清除

Biodistribution and clearance of 125I-labeled C-reactive protein and 125I-labeled modified C-reactive protein in CD-1 mice.

作者信息

Motie M, Schaul K W, Potempa L A

机构信息

Immtech International Inc., Evanston, IL 60201, USA.

出版信息

Drug Metab Dispos. 1998 Oct;26(10):977-81.

PMID:9763402
Abstract

Iodinated forms of C-reactive protein (CRP), soluble modified CRP (mCRP-sol), and suspended mCRP (mCRP-susp) were injected iv into CD-1 mice, for analysis of their pharmacokinetics (PK) and biodistribution (BD). The plasma half-life of 125I-CRP, measured as 4.7 hr, agrees closely with previous reports. The PK and BD characteristics for 125I-mCRP-sol and 125I-mCRP-susp were comparable to each other and were distinctly different from those measured for CRP. Whereas approximately 50% of 125I-CRP was recoverable from plasma 5 min after injection, only approximately 5% of 125I-mCRP was similarly recoverable. The estimated volume of distribution at steady state calculated for either form of 125I-mCRP was approximately 10-fold greater than that calculated for 125I-CRP (23. 4-27.6 and 2.4 ml, respectively). The estimated mean residence times for 125I-mCRP were approximately 2 times longer than that measured for 125I-CRP (9.5-11.5 hr, compared with 4.9 hr). At both 4- and 24-hr time points, substantial amounts of 125I-mCRP were selectively distributed in the bone marrow. At 24 hr, approximately 25% of the injected 125I-mCRP-sol and 125I-mCRP-susp was localized to the bone marrow (corresponding to 92% of injected dose/g of tissue). At this time point, only 8% (or 27%/g) of 125I-CRP was localized to the bone marrow. Overall, the data presented indicate that 1) mCRP has PK and BD characteristics distinct from those of CRP; 2) injected mCRP, although it is rapidly cleared from the general circulation, accesses large body areas and is selectively localized to the bone marrow; and 3) all forms of CRP appear to be excreted in the urine.

摘要

将碘标记形式的C反应蛋白(CRP)、可溶性修饰CRP(mCRP-sol)和悬浮mCRP(mCRP-susp)静脉注射到CD-1小鼠体内,以分析它们的药代动力学(PK)和生物分布(BD)。125I-CRP的血浆半衰期测定为4.7小时,与先前的报道非常一致。125I-mCRP-sol和125I-mCRP-susp的PK和BD特征彼此相当,且与CRP的测量结果明显不同。注射后5分钟,约50%的125I-CRP可从血浆中回收,而类似地,只有约5%的125I-mCRP可回收。为两种形式的125I-mCRP计算的稳态分布容积估计值比为125I-CRP计算的值大约10倍(分别为23.4 - 27.6和2.4 ml)。125I-mCRP的估计平均驻留时间比125I-CRP测量的时间长约2倍(分别为9.5 - 11.5小时和4.9小时)。在4小时和24小时时间点,大量的125I-mCRP选择性地分布在骨髓中。在24小时时,注射的125I-mCRP-sol和125I-mCRP-susp中约25%定位于骨髓(相当于每克组织注射剂量的92%)。在这个时间点,只有8%(或每克27%)的125I-CRP定位于骨髓。总体而言,所呈现的数据表明:1)mCRP具有与CRP不同的PK和BD特征;2)注射的mCRP虽然从体循环中迅速清除,但可进入身体的大片区域并选择性地定位于骨髓;3)所有形式的CRP似乎都通过尿液排泄。

相似文献

1
Biodistribution and clearance of 125I-labeled C-reactive protein and 125I-labeled modified C-reactive protein in CD-1 mice.125I标记的C反应蛋白和125I标记的修饰C反应蛋白在CD-1小鼠体内的生物分布与清除
Drug Metab Dispos. 1998 Oct;26(10):977-81.
2
Stimulation of megakaryocytopoiesis in mice by human modified C-reactive protein (mCRP).人修饰C反应蛋白(mCRP)对小鼠巨核细胞生成的刺激作用。
Exp Hematol. 1996 Feb;24(2):258-64.
3
Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice.天然C反应蛋白增加,而修饰后的C反应蛋白减少载脂蛋白E基因敲除小鼠的动脉粥样硬化。
Circulation. 2005 Aug 16;112(7):1016-23. doi: 10.1161/CIRCULATIONAHA.105.556530. Epub 2005 Aug 8.
4
Native and modified C-reactive protein bind different receptors on human neutrophils.天然和修饰的C反应蛋白与人中性粒细胞上的不同受体结合。
Int J Biochem Cell Biol. 2005 Feb;37(2):320-35. doi: 10.1016/j.biocel.2004.07.002.
5
Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions.修饰型C反应蛋白对补体激活的影响:修饰型或单体型C反应蛋白在动脉粥样硬化病变中可能的补体调节作用。
Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):935-41. doi: 10.1161/01.ATV.0000206211.21895.73. Epub 2006 Feb 2.
6
Binding of model soluble immune complexes to modified C-reactive protein.模型可溶性免疫复合物与修饰的C反应蛋白的结合
J Immunol. 1996 Jun 1;156(11):4435-41.
7
Opposing effects of C-reactive protein isoforms on shear-induced neutrophil-platelet adhesion and neutrophil aggregation in whole blood.C反应蛋白异构体对全血中剪切力诱导的中性粒细胞与血小板黏附及中性粒细胞聚集的相反作用。
Circulation. 2004 Oct 26;110(17):2713-20. doi: 10.1161/01.CIR.0000146846.00816.DD. Epub 2004 Oct 18.
8
Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.125I标记的B淋巴细胞刺激因子在小鼠体内快速且特异性地靶向淋巴组织和B细胞肿瘤。
J Nucl Med. 2003 Mar;44(3):422-33.
9
Loss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils.C反应蛋白中五聚体对称性的丧失通过过氧亚硝酸盐信号通路诱导人中性粒细胞分泌白细胞介素-8。
Circ Res. 2005 Sep 30;97(7):690-7. doi: 10.1161/01.RES.0000183881.11739.CB. Epub 2005 Aug 25.
10
Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m).细胞膜和脂质体可使C反应蛋白(CRP)解离,形成一种新的、具有生物活性的结构中间体:mCRP(m)。
FASEB J. 2007 Jan;21(1):284-94. doi: 10.1096/fj.06-6722com. Epub 2006 Nov 20.

引用本文的文献

1
Redefining CRP in tissue injury and repair: more than an acute pro-inflammatory mediator.重新定义组织损伤与修复中的C反应蛋白:不仅仅是一种急性促炎介质。
Front Immunol. 2025 Feb 28;16:1564607. doi: 10.3389/fimmu.2025.1564607. eCollection 2025.
2
Regulation of Conformational Changes in C-reactive Protein Alters its Bioactivity.C反应蛋白构象变化的调控改变其生物活性。
Cell Biochem Biophys. 2022 Dec;80(4):595-608. doi: 10.1007/s12013-022-01089-x. Epub 2022 Aug 23.
3
Intra-subunit Disulfide Determines the Conversion and Structural Stability of CRP Isoforms.
亚基内二硫键决定 CRP 同型异构体的转换和结构稳定性。
Inflammation. 2020 Apr;43(2):466-477. doi: 10.1007/s10753-019-01130-x.
4
Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites.CRP 结构的转变导致了炎症结合位点的暴露。
Nat Commun. 2017 Jan 23;8:14188. doi: 10.1038/ncomms14188.
5
Targeting C-Reactive Protein in Inflammatory Disease by Preventing Conformational Changes.通过防止构象变化来靶向炎症性疾病中的C反应蛋白
Mediators Inflamm. 2015;2015:372432. doi: 10.1155/2015/372432. Epub 2015 May 18.
6
C-reactive protein protects mice against pneumococcal infection via both phosphocholine-dependent and phosphocholine-independent mechanisms.C反应蛋白通过磷酸胆碱依赖性和非磷酸胆碱依赖性机制保护小鼠免受肺炎球菌感染。
Infect Immun. 2015 May;83(5):1845-52. doi: 10.1128/IAI.03058-14. Epub 2015 Feb 17.
7
Comparison of succinimidyl [(125)I]iodobenzoate with iodogen iodination methods to study pharmacokinetics and ADME of biotherapeutics.琥珀酰亚胺基[(125)I]碘苯甲酸酯与碘甘氨酸碘化法在生物治疗药物药代动力学和药物处置、代谢及排泄研究中的比较。
Pharm Res. 2014 Oct;31(10):2810-21. doi: 10.1007/s11095-014-1378-3. Epub 2014 May 21.
8
Topological localization of monomeric C-reactive protein determines proinflammatory endothelial cell responses.单体C反应蛋白的拓扑定位决定促炎内皮细胞反应。
J Biol Chem. 2014 May 16;289(20):14283-90. doi: 10.1074/jbc.M114.555318. Epub 2014 Apr 7.
9
Binding of the monomeric form of C-reactive protein to enzymatically-modified low-density lipoprotein: effects of phosphoethanolamine.C反应蛋白单体形式与酶修饰低密度脂蛋白的结合:磷酸乙醇胺的作用
Clin Chim Acta. 2009 Aug;406(1-2):151-5. doi: 10.1016/j.cca.2009.06.018. Epub 2009 Jun 21.
10
The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.人C反应蛋白在肺炎链球菌感染小鼠模型中的保护作用。
Endocr Metab Immune Disord Drug Targets. 2008 Dec;8(4):231-7. doi: 10.2174/187153008786848321.